Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hogy Medical Co's ROE % for the quarter that ended in Dec. 2025 was 2.87%. Hogy Medical Co's PB Ratio for the quarter that ended in Dec. 2025 was 1.93.
Hogy Medical Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 1.49%.
Hogy Medical Co ROE % Adjusted to Book Value Related Terms
Hogy Medical Co ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Hogy Medical Co's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hogy Medical Co ROE % Adjusted to Book Value Chart
TSE:3593 vs ISRG, BDX, MDLN: ROE % Adjusted to Book Value Comparison
For the Medical Instruments & Supplies subindustry, Hogy Medical Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hogy Medical Co ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hogy Medical Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Hogy Medical Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 1.49% mean?
Hogy Medical Co (TSE:3593) has a ROE % Adjusted to Book Value of 1.49% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Hogy Medical Co and its competitors.
Is Hogy Medical Co's ROE % Adjusted to Book Value too high?
Hogy Medical Co's current ROE % Adjusted to Book Value is 1.49%. Overall, Hogy Medical Co has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hogy Medical Co's ROE % Adjusted to Book Value compare to ISRG and BDX?
Hogy Medical Co's ROE % Adjusted to Book Value of 1.49% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Hogy Medical Co and its competitors. Hogy Medical Co's current ROE % Adjusted to Book Value is 1.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hogy Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Hogy Medical Co (TSE:3593) is currently considered Significantly Overvalued. The stock's GF Value™ is 円4,422.15, compared to a current price of 円6,660.00 — trading 50.6% above its estimated fair value. The current ROE % Adjusted to Book Value is 1.49%. Hogy Medical Co's overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Hogy Medical Co (TSE:3593), the current ROE % Adjusted to Book Value is 1.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hogy Medical Co (TSE:3593) Overvalued in 2026?
Based on GuruFocus' analysis, Hogy Medical Co stock appears to be overvalued.
The current stock price of 円6,660.00 is trading 50.6% above its estimated GF Value™ of 円4,422.15.
GuruFocus considers Hogy Medical Co to be Significantly Overvalued.
Key valuation signals for TSE:3593:
ROE % Adjusted to Book Value: 1.49%
GF Value™: 円4,422.15 vs. price of 円6,660.00 (50.6% above fair value)
No single metric tells the full story. See the TSE:3593 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hogy Medical Co Ltd develops and sells products that can be used to streamline operations and improve safety at healthcare facilities. Its products are used in hospitals' operating rooms, wards, material rooms, and administrative settings. Hogy Medical receives the majority of its revenue from sales of surgical-use products. Its key products include kit products, nonwoven products, and sterilization products. The kit products contain sterilized surgical supplies for use in a specific operation. The nonwoven products include gowns, caps, equipment covers, and other accessories. Hogy's primary sterilization product is the Mekkin bag, a sterilization pouch. The vast majority of Hogy's revenue is generated in Japan.
47GF Score
Get the complete analysis for TSE:3593
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3593 has been successfully added to your 
